These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 26844979)

  • 1. Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
    Punja S; Shamseer L; Hartling L; Urichuk L; Vandermeer B; Nikles J; Vohra S
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD009996. PubMed ID: 26844979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.
    Castells X; Blanco-Silvente L; Cunill R
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD007813. PubMed ID: 30091808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
    Storebø OJ; Ramstad E; Krogh HB; Nilausen TD; Skoog M; Holmskov M; Rosendal S; Groth C; Magnusson FL; Moreira-Maia CR; Gillies D; Buch Rasmussen K; Gauci D; Zwi M; Kirubakaran R; Forsbøl B; Simonsen E; Gluud C
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009885. PubMed ID: 26599576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
    Storebø OJ; Storm MRO; Pereira Ribeiro J; Skoog M; Groth C; Callesen HE; Schaug JP; Darling Rasmussen P; Huus CL; Zwi M; Kirubakaran R; Simonsen E; Gluud C
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD009885. PubMed ID: 36971690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Cândido RCF; Menezes de Padua CA; Golder S; Junqueira DR
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013011. PubMed ID: 33460048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylphenidate for children and adolescents with autism spectrum disorder.
    Sturman N; Deckx L; van Driel ML
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011144. PubMed ID: 29159857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults.
    Castells X; Ramos-Quiroga JA; Bosch R; Nogueira M; Casas M
    Cochrane Database Syst Rev; 2011 Jun; (6):CD007813. PubMed ID: 21678370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.
    Storebø OJ; Pedersen N; Ramstad E; Kielsholm ML; Nielsen SS; Krogh HB; Moreira-Maia CR; Magnusson FL; Holmskov M; Gerner T; Skoog M; Rosendal S; Groth C; Gillies D; Buch Rasmussen K; Gauci D; Zwi M; Kirubakaran R; Håkonsen SJ; Aagaard L; Simonsen E; Gluud C
    Cochrane Database Syst Rev; 2018 May; 5(5):CD012069. PubMed ID: 29744873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
    Otasowie J; Castells X; Ehimare UP; Smith CH
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD006997. PubMed ID: 25238582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
    Gillies D; Sinn JKh; Lad SS; Leach MJ; Ross MJ
    Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD007986. PubMed ID: 22786509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Boesen K; Paludan-Müller AS; Gøtzsche PC; Jørgensen KJ
    Cochrane Database Syst Rev; 2022 Feb; 2(2):CD012857. PubMed ID: 35201607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Epstein T; Patsopoulos NA; Weiser M
    Cochrane Database Syst Rev; 2014 Sep; (9):CD005041. PubMed ID: 25230710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
    Gillies D; Leach MJ; Perez Algorta G
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD007986. PubMed ID: 37058600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.
    Verbeeck W; Bekkering GE; Van den Noortgate W; Kramers C
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009504. PubMed ID: 28965364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy.
    Eaton C; Yong K; Walter V; Mbizvo GK; Rhodes S; Chin RF
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013136. PubMed ID: 35844168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis.
    Cortese S; Adamo N; Del Giovane C; Mohr-Jensen C; Hayes AJ; Carucci S; Atkinson LZ; Tessari L; Banaschewski T; Coghill D; Hollis C; Simonoff E; Zuddas A; Barbui C; Purgato M; Steinhausen HC; Shokraneh F; Xia J; Cipriani A
    Lancet Psychiatry; 2018 Sep; 5(9):727-738. PubMed ID: 30097390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years.
    Storebø OJ; Elmose Andersen M; Skoog M; Joost Hansen S; Simonsen E; Pedersen N; Tendal B; Callesen HE; Faltinsen E; Gluud C
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD008223. PubMed ID: 31222721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological interventions for somatoform disorders in adults.
    Kleinstäuber M; Witthöft M; Steffanowski A; van Marwijk H; Hiller W; Lambert MJ
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010628. PubMed ID: 25379990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.